Navigation Links
Pioneering Neurosciences Institute Sets Date for Dedication of New Facility and First-Ever International Forum on Memory and Memory Disorders
Date:8/26/2008

ON OCTOBER 16 WORLD-RENOWNED SCIENTISTS WILL CONVENE TO SHARE CUTTING EDGE RESEARCH ON ALZHEIMER'S DISEASE, MEMORY AND AGING

MORGANTOWN, W.Va., Aug. 26 /PRNewswire-USNewswire/ -- On October 16th, 2008, the new $30 million Blanchette Rockefeller Neurosciences Institute (BRNI) located on the campus on West Virginia University and founded in honor of U.S. Senator Jay Rockefeller's mother, will play host to prominent international scientists who are advancing research on Alzheimer's disease and other memory disorders. The first-ever International Forum on Memory and Memory Disorders will highlight the work of nine celebrated scientists whose research has led to breakthrough advances for the aging brain, Alzheimer's disease, and patients suffering from memory loss and memory disorders. The next day, on October 17, BRNI will open its doors to the public and further continue the Institute's research, which started nearly nine years ago. The approximately 78,000 square foot three-level building will provide state-of-the-art laboratory space and support research activities for nearly a hundred scientists and researchers.

"Even before the doors have opened, BRNI has undertaken ground-breaking research into the treatment for Alzheimer's and other neurological disorders. Now, for the first time ever, the best and brightest minds in our country, and from around the world, will gather to discuss the state of memory and memory disorders research and have a place to carry on their important work," said Sen. Rockefeller. "I know the heartbreak that comes with having someone you love slowly fade from Alzheimer's. BRNI's opening is a great day for not only West Virginia, but for all families across the globe that will benefit from its important work."

The prestigious list of scientists chosen to share their research is an international mix of experts from Switzerland, to Harvard Medical School, to West Virginia University and includes:

Professor Floyd Bloom, Professor Emeritus and Chairman of Neuropharmacology, The Scripps Institute, Professor Andrew Matus, Director, Emeritus Neurobiology, Friedrich Miescher Institute, Novartis Research Foundation, Switzerland, Professor Howard Eichenbaum, Director, Center for Memory, Boston University, Professor Tracy Shors, Department of Psychology, Center for Collaborative Neuroscience, Rutgers University, Dr. Daniel Alkon, Scientific Director, Blanchette Rockefeller Neurosciences Institute at West Virginia University, Professor Rudi Tanzi, Director, Genetics and Aging Unit, Harvard Medical School, Professor Sangram Sisodia, Director, Center for Brain Disease, University of Chicago, Professor James Stevenson, Chairman, Department of Behavioral Medicine and Psychiatry, West Virginia University School of Medicine and Professor Carol Barnes, Director, Evelyn F. McKnight Brain Institute, The University of Arizona.

"Because of the dedication of Sen. Rockefeller and his passion for finding a cure for Alzheimer's, this magnificent facility and its outstanding world-renowned scientists can work everyday to unlock the causes and treatments for this troubling disease," said Dr. Daniel Alkon, Scientific Director at BRNI. "BRNI's hosting of the International Forum on Memory and Memory Disorders will shine a global spotlight on our own work and contribute to the progress we are making in finding a cure for Alzheimer's disease and new undiscovered treatments for memory disorders."

The only non-profit independent institution in the world dedicated to the study of human memory and memory disorders, BRNI was established by Rockefeller in 1999 in honor of his mother, Blanchette, who was afflicted by Alzheimer's disease. The Institute's scientific exploration of memory and memory disorders has led to recent discoveries with a drug - Bryostatin - shown to create new connections in the brain, among other revolutionary findings. BRNI's work expands and advances the scientific research of memory and memory disorders for the purposes of prevention, diagnosis and treatment, with the goal of moving research out of the laboratory and into the hands of physicians and patients.

For more information on the Blanchette Rockefeller Neurosciences Institute or to register to attend the International Forum, visit http://www.brni.org.

About Blanchette Rockefeller Neurosciences Institute:

Created in 1999, BRNI is the world's only non-profit institute dedicated to the study of both human memory and diseases of memory. Its primary mission is to accelerate neurological discoveries from the lab, including diagnostic tools and treatments, to the clinic where it can benefit patients who suffer from neurological and psychiatric diseases.

BRNI is operated in alliance with West Virginia University in Morgantown as well as in collaboration with other academic institutions such as Johns Hopkins University. West Virginia Senator Jay Rockefeller founded the Institute in memory of his mother, Blanchette Hooker Rockefeller, who died of Alzheimer's disease.


'/>"/>
SOURCE Blanchette Rockefeller Neurosciences Institute
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Frost & Sullivan Recognizes Waters Corporation for Its Pioneering, High Customer Value Analytical Instrumentation Product, SYNAPT HDMS
2. Pioneering stroke researcher awarded Canadas highest honor
3. Pioneering Solutions To Fight Staph, MRSA Infections in Sports Facilities and Synthetic Turf Fields
4. Pioneering Safe Medication Return Initiative Reviewed During Pharmaceutical Disposal Summit
5. Kavli Prize awarded to Pasko Rakic, pioneering Yale neuroscientist
6. Heart stem cell scientist to honor pioneering woman scientist in keynote speech
7. Pioneering Heart Surgeon, Robert E. Michler, M.D., Appointed Chair of Surgery and Surgeon-in-Chief at Einstein and at Montefiore Medical Center
8. Acclaimed A LION IN THE HOUSE Team Honored in Washington for Pioneering Work on Pediatric Cancer
9. WRAIR investigators pioneering work on an exciting new class of antimalarial compounds
10. Reproductive Medicine & Fertility Center is First in Southwest to Offer Pioneering Test of a Womens Biological Clock
11. Boston IVF is First in Northeast to Offer Pioneering Test of Womens Biological Clock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... ... February 05, 2016 , ... Today, the Whole-Food Warrior TV show, ... much-anticipated feature with author Jahnavi Foster, specialist in healthy vegetarian cuisine, will stream on ... week, on his weekly Whole-Food Warrior TV show, Frank Davis highlights Whole-Food Warriors - ...
(Date:2/5/2016)... ... February 05, 2016 , ... The event is being held on April ... in Minneapolis, Minn. Triumph Over Parkinson’s will fund nearly $100,000 for research for the ... lives with Parkinson’s disease and is the architect of this informative event to raise ...
(Date:2/5/2016)... ... February 05, 2016 , ... Francisco Canales, ... services in their Napa Valley office. The technique utilizes the body’s own healing ... Canales and Dr. Furnas, are part of only a select few cosmetic surgeons ...
(Date:2/5/2016)... , ... February 05, 2016 , ... ... President George H. Van Allen have signed a joint enrollment and degree completion ... seamless pathway toward associate and baccalaureate degrees at FHU|Dickson. , The agreement ...
(Date:2/5/2016)... ... February 05, 2016 , ... The Lymphoma ... innovative lymphoma research and serving the lymphoma community through a comprehensive series of ... host, Swirl, A Wine Tasting Event at the La Gorce Country Club in ...
Breaking Medicine News(10 mins):
(Date:2/5/2016)... Calif. , Feb. 5, 2016  Syneron ... global aesthetic device company, announced today that ... Candela North America, is scheduled to participate in ... Healthcare Conference on February 11, 2016 in ... will allow institutional investors to meet with the ...
(Date:2/5/2016)...  Aralez Pharmaceuticals Inc. ("Aralez") today announced the completion ... Pharmaceuticals Canada Inc. ("Tribute") following approval of the transaction ... combined company will operate under Aralez Pharmaceuticals Inc. ("Aralez"), ... Canada , Ireland ... the terms of the Agreement and Plan of Merger ...
(Date:2/5/2016)... --> --> ... the global active pharmaceuticals ingredients (APIs) market stood at ... US$185.9 bn by 2020. It is expected to expand ... The title of the report is "Active Pharmaceutical Ingredients ... by Therapeutic Area) - Global Industry Analysis, Size, Share, ...
Breaking Medicine Technology: